LEADER 02982nam 2200493 a 450 001 9910698381203321 005 20071107124205.0 035 $a(CKB)25434725400041 035 $a(OCoLC)180864258 035 $a(EXLCZ)9925434725400041 100 $a20071107d2007 ua 0 101 0 $aeng 135 $aurmn||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aOpium and Afghanistan$b[electronic resource] $ereassessing U.S. counternarcotics strategy /$fJohn A. Glaze 210 1$aCarlisle, PA :$cStrategic Studies Institute, U.S. Army War College,$d[2007] 215 $av, 18 pages $cdigital, PDF file 225 1 $aCarlisle papers in security strategy 300 $aTitle from title screen (viewed on Oct. 30, 2007). 300 $a"October 2007." 320 $aIncludes bibliographical references (pages 14-18). 327 $aBackground -- Afghanistan's opium economy -- Problems with Afghanistan's opium economy -- Renewed Taliban/insurgency -- Current counternarcotics strategy -- Problems with current counternarcotics strategy -- Recommendations -- Conclusion. 330 0 $aCultivation and production of opium in Afghanistan has skyrocketed since the Taliban were toppled in 2001such that Afghanistan now supplies 92 percent of the world's illicit opium. The expanding opium trade is threatening to destabilize the Afghan government and turn the conflict-ridden country back into a safe haven for drug traffickers and terrorists. This paper examines the nature of the opium problem in Afghanistan and analyzes the allied strategy to counter this growing crisis. In analyzing the current counternarcotics strategy, it points out pitfalls including the counterproductive aspects of opium eradication. Finally, changes to the strategy are proposed, which include increasing troop levels and eliminating national restrictions, substantially increasing financial aid, deemphasizing opium eradication, focusing on long-term alternative livelihoods, aggressively pursuing drug kingpins and corrupt government officials, and exploring the possibility of Afghanistan's entry to the licit opium market. 517 3 $aOpium and Afghanistan :$ereassessing United States counternarcotics strategy 517 3 $aReassessing U.S. counternarcotics strategy 606 $aOpium trade$zAfghanistan 606 $aDrug traffic$zAfghanistan$xPrevention 606 $aNarco-terrorism$zAfghanistan$xPrevention 606 $aDrug control$zAfghanistan 607 $aAfghanistan$xPolitics and government$y2001- 615 0$aOpium trade 615 0$aDrug traffic$xPrevention. 615 0$aNarco-terrorism$xPrevention. 615 0$aDrug control 700 $aGlaze$b John A$01417836 712 02$aArmy War College (U.S.).$bStrategic Studies Institute. 801 0$bGPO 801 1$bGPO 906 $aBOOK 912 $a9910698381203321 996 $aOpium and Afghanistan$93527453 997 $aUNINA LEADER 04139nam 2200961z- 450 001 9910557748703321 005 20220111 035 $a(CKB)5400000000045855 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/76656 035 $a(oapen)doab76656 035 $a(EXLCZ)995400000000045855 100 $a20202201d2021 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aBiocomposite Inks for 3D Printing 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021 215 $a1 online resource (213 p.) 311 08$a3-0365-1738-3 311 08$a3-0365-1737-5 330 $aThree-dimensional (3D) printing has evolved massively during the last years. The 3D printing technologies offer various advantages, including: i) tailor-made design, ii) rapid prototyping, and iii) manufacturing of complex structures. Importantly, 3D printing is currently finding its potential in tissue engineering, wound dressings, tissue models for drug testing, prosthesis, and biosensors, to name a few. One important factor is the optimized composition of inks that can facilitate the deposition of cells, fabrication of vascularized tissue and the structuring of complex constructs that are similar to functional organs. Biocomposite inks can include synthetic and natural polymers, such as poly (?-caprolactone), polylactic acid, collagen, hyaluronic acid, alginate, nanocellulose, and may be complemented with cross-linkers to stabilize the constructs and with bioactive molecules to add functionality. Inks that contain living cells are referred to as bioinks and the process as 3D bioprinting. Some of the key aspects of the formulation of bioinks are, e.g., the tailoring of mechanical properties, biocompatibility and the rheological behavior of the ink which may affect the cell viability, proliferation, and cell differentiation.The current Special Issue emphasizes the bio-technological engineering of novel biocomposite inks for various 3D printing technologies, also considering important aspects in the production and use of bioinks. 606 $aInformation technology industries$2bicssc 610 $a3D bioprinting 610 $a3D cell culture 610 $a3D printing 610 $aabsorption 610 $aadditive manufacturing 610 $aartificial limb 610 $abacteria biofabrication 610 $abacterial nanocellulose 610 $abioactive scaffold 610 $abiocomposite 610 $abiocomposite ink 610 $abiofabrication 610 $abioink 610 $abioinks 610 $abiomanufacturing 610 $abiomedicine 610 $abioprinting 610 $acancer 610 $acancer stemness 610 $acarboxylated agarose 610 $acellulose 610 $acellulose nanocrystals 610 $acellulose nanofibrils 610 $aclinical translational 610 $aCNF 610 $acollagen 610 $acytotoxicity 610 $adrug delivery 610 $aECM 610 $aextracellular matrix 610 $afibrils 610 $aforest-based MFC 610 $afree-standing 610 $afused deposition modeling (FDM) 610 $agrowth factor cocktail 610 $ahuman nasal chondrocytes 610 $ahydrogel 610 $ahydrogels 610 $an/a 610 $ananocellulose 610 $aphysical cross-linking 610 $apine sawdust 610 $apolyhydroxyalkanoates 610 $aprintability 610 $aprobiotic food 610 $ascaffolds 610 $asoda ethanol pulping 610 $atissue engineering 610 $atubular organ 610 $atubular tissue 610 $avessel stenting 610 $awound dressings 615 7$aInformation technology industries 700 $aCarrasco$b Gary$4edt$01278408 702 $aCarrasco$b Gary$4oth 906 $aBOOK 912 $a9910557748703321 996 $aBiocomposite Inks for 3D Printing$93013232 997 $aUNINA